Clinical Overview
Risperidone is one of the first atypical antipsychotics, indicated for schizophrenia, bipolar disorder, and autism-related irritability. It has a well-established efficacy and safety profile across multiple age groups and is available in oral and long-acting injectable formulations. It demonstrates potent dopamine D2 and serotonin 5-HT2A receptor antagonism with dose-dependent side effects.
Primary Clinical Applications
Risperidone is indicated for schizophrenia in adults and adolescents, bipolar I disorder (manic or mixed episodes), and irritability associated with autism spectrum disorder in children and adolescents. It is often considered a first-line atypical antipsychotic due to its extensive evidence base and availability of multiple formulations.
Mechanism and Clinical Benefits
Risperidone antagonizes dopamine D2 receptors and serotonin 5-HT2A receptors with high affinity, providing antipsychotic efficacy while potentially reducing extrapyramidal side effects compared to typical antipsychotics. It also has activity at alpha-1 adrenergic and histamine H1 receptors, contributing to some side effects.
Clinical Considerations
Risperidone has dose-dependent side effects, with lower doses having fewer extrapyramidal symptoms but higher doses approaching typical antipsychotic side effect profiles. It can cause significant prolactin elevation and metabolic effects. The long-acting injectable formulation improves adherence for maintenance therapy.
Prescribing Information
Dosing & Administration
Schizophrenia – Adults:
- Initial: 2 mg daily (1 mg twice daily or 2 mg once daily)
- Titration: Increase by 1-2 mg daily on day 2, then adjust weekly
- Range: 4-8 mg daily
- Maximum: 16 mg daily
Schizophrenia – Adolescents (13-17 years):
- Initial: 0.5 mg once daily
- Titration: Increase by 0.5-1 mg daily, adjust every 24+ hours
- Range: 1-6 mg daily
Bipolar I Disorder – Adults:
- Initial: 2-3 mg once daily
- Range: 1-6 mg daily
Autism-Related Irritability (5-17 years):
- <20 kg: 0.25 mg daily initially, range 0.5-3 mg daily
- ≥20 kg: 0.5 mg daily initially, range 0.5-3 mg daily
Long-Acting Injectable (Consta):
- Dose: 25 mg IM every 2 weeks
- Range: 25-50 mg every 2 weeks
- Oral overlap: Continue oral risperidone for 3 weeks after first injection
Indications
- Treatment of schizophrenia (adults and adolescents 13-17 years)
- Treatment of acute manic or mixed episodes of bipolar I disorder (adults and children 10-17 years)
- Maintenance treatment of bipolar I disorder
- Treatment of irritability associated with autism spectrum disorder (children and adolescents 5-17 years)
Contraindications
- Known hypersensitivity to risperidone or any component
- No absolute contraindications
Warnings & Precautions
- Boxed Warning: Increased mortality in elderly patients with dementia-related psychosis; increased suicidal thoughts in children, adolescents, and young adults
- Hyperprolactinemia: Significant elevation, monitor prolactin levels
- Metabolic changes: Monitor glucose, lipids, and weight
- Extrapyramidal symptoms: Dose-related risk
- Tardive dyskinesia: Risk with long-term use
- Neuroleptic malignant syndrome: Rare but serious risk
- Orthostatic hypotension: Monitor blood pressure
Drug Interactions
- CYP2D6 inhibitors: Increase risperidone levels
- CYP3A4 inducers: Decrease risperidone levels
- CNS depressants: Enhanced sedation
- Antihypertensives: Enhanced hypotensive effects
Adverse Reactions
Common (≥5%):
- Parkinsonism, akathisia, dystonia, tremor
- Somnolence, dizziness, constipation, nausea
- Weight gain, fatigue, dry mouth
Endocrine:
- Hyperprolactinemia, galactorrhea, amenorrhea
Special Populations
- Renal/Hepatic Impairment: Start with 0.5 mg twice daily, titrate slowly
- Elderly: Increased mortality risk in dementia-related psychosis
- Pregnancy: Category C – use only if benefits outweigh risks
- Pediatric: Monitor growth and development
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
